Success Metrics

Clinical Success Rate
100.0%

Based on 10 completed trials

Completion Rate
100%(10/10)
Active Trials
0(0%)
Results Posted
50%(5 trials)

Phase Distribution

Ph not_applicable
13
93%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution13 total trials
N/ANon-phased studies
13(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

10 of 10 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

14

all time

Status Distribution
Active(1)
Completed(10)
Other(3)

Detailed Status

Completed10
unknown3
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
14
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A13 (100.0%)

Trials by Status

not_yet_recruiting17%
unknown321%
completed1071%

Recent Activity

Clinical Trials (14)

Showing 14 of 14 trials
NCT07230847Not Applicable

A Study Evaluating the Vascular Healing and Neointimal Transformation at 1 Month After Implantation of BioFreedom™ Drug-coated Stents and the Xience Drug-eluting Stent System in Patients With Acute Coronary Syndrome and High Bleeding Risk Using Optical Coherence Tomography

Not Yet Recruiting
NCT03440801Not Applicable

A Randomized Comparison of Long-Term Healing Between Biodegradable- Versus Durable-Polymer Everolimus Eluting Stents in STEMI

Completed
NCT02173379Not Applicable

Absorb IV Randomized Controlled Trial

Completed
NCT02890160Not Applicable

A Trial of Firesorb in Patients With Coronary Artery Disease: FUTURE-II

Unknown
NCT01751906Not Applicable

ABSORB III Randomized Controlled Trial (RCT)

Completed
NCT03815175Not Applicable

XIENCE 28 USA Study

Completed
NCT03218787Not Applicable

XIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HBR Patients.

Completed
NCT03355742Not Applicable

XIENCE 28 Global Study

Completed
NCT02870140Not Applicable

Thin Strut Sirolimus-eluting Stent in All Comers Population vs Everolimus-eluting Stent

Completed
NCT02579031Not Applicable

A Comparison of an Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Stent With a Durable Polymer Everolimus-Eluting Stent for Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

Completed
NCT03049657Not Applicable

Efficacy of Angiolite Stent vs a Second-generation Drug-eluting Stent Xience for Percutaneous Coronary Intervention

Completed
NCT01858077Not Applicable

Amsterdam Investigator-initiateD Absorb Strategy All-comers Trial

Unknown
NCT02486068Not Applicable

ABSORB Bioresorbable Scaffold vs. Xience Metallic Stent for Prevention of Restenosis in Patients at High Risk of Restenosis

Unknown
NCT01350869

Evaluation of Everolimus-Eluting Stents (The K-XIENCE Registry)

Completed

All 14 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
14